Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Microneedles help improve skin appearance and deliver skin treatments effectively, but safety concerns need more research and regulation.

Normal skin cell renewal doesn't need RAR signaling, but vitamin A-related skin thickening does.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

Eating fewer calories, less sugar and refined carbs, and more low-glycemic and omega-3 rich foods can help manage PCOS symptoms.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Toxic Shock Syndrome progresses quickly, often involves multiple organs, and is linked to Staphylococcus aureus toxins, with treatment options available but diagnostic challenges remaining.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Some hair loss can be treated, especially in women due to nutrition, but some types remain untreatable.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Dandruff is a common, winter-worsened scalp condition linked to inflammation and microorganisms, treatable with products like ketoconazole, and may affect hair loss.

Reconstruct lips with proper planning, templates, and revisions for appearance and function.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.

Ketoconazole lotion can improve hair regrowth for some people with androgenetic alopecia.

Minoxidil can cause skin irritation like eczema and rash in some users.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hair restoration surgery has advanced, focusing on natural results and may improve further with new techniques and therapies.

Stress activates a special function of the Vitamin D receptor with the help of c-Jun, which can also prevent cell death.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

The research suggests that Tourette syndrome is linked to both brain signaling and immune system pathways.